A group of investors, including family offices, Carlos Slim, and Royalty Pharma's chairman, Pablo LaGretta, invested half a billion dollars in a business that aims to provide a solution for chronic kidney disease. By using a patient's own body to heal their kidneys, the business hopes to help those with chronic kidney disease or on dialysis.